Back
Hyatt Hotels Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
24
H
Hyatt Hotels
Last Price:
$140.95
Seasonality Move:
-1.35%
Sell
37
DRUG
Bright Minds Biosciences
Last Price:
$37.50
Seasonality Move:
-32.13%
Sell
24
Hyatt Hotels (H)
is a Sell
Is Hyatt Hotels a Buy, Sell or Hold?
-
The current Hyatt Hotels [H] share price is $140.95. The Score for H is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
H is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $37.39. The Score for DRUG is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
H Stock Price Chart
What is Hyatt Hotels's stock price today?
-
The Hyatt Hotels share price today is $140.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and H is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $37.39The current trend is relatively stagnant and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
H Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.65 | Sell |
Relative Strength Index (14 RSI): | 37.03 | Sell |
Chaikin Money Flow: | 304784 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (143.91 - 161.15) | Sell |
Bollinger Bands (100): | (148.81 - 160.15) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 49.78 | Sell |
Chaikin Money Flow: | 27952 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.12 - 42.26) | Buy |
Bollinger Bands (100): | (24.86 - 48.56) | Buy |
H Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 142.15 | Sell |
20-day SMA: | 151.58 | Sell |
50-day SMA: | 154.24 | Sell |
200-day SMA: | 151.2 | Sell |
8-day EMA: | 142.77 | Sell |
20-day EMA: | 148.27 | Sell |
50-day EMA: | 152.39 | Sell |
200-day EMA: | 149.81 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.75 | Buy |
20-day SMA: | 38.76 | Sell |
50-day SMA: | 37.71 | Sell |
200-day SMA: | 18.92 | Buy |
8-day EMA: | 36.45 | Buy |
20-day EMA: | 37.51 | Sell |
50-day EMA: | 37.11 | Buy |
200-day EMA: | 24.13 | Buy |
Hyatt Hotels Earnings Growth & H Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.64 per share, and an increase next year of $1.17 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Hyatt Hotels Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |